Jang, H. N., & Jung, H. S. (2020). Response: Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang et al.). Endocrinol Metab (Seoul).
Citação norma ChicagoJang, Han Na, and Hye Seung Jung. "Response: Favorable Glycemic Control With Once-Daily Insulin Degludec/Insulin Aspart After Changing From Basal Insulin in Adults With Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang Et Al.)." Endocrinol Metab (Seoul) 2020.
ציטוט MLAJang, Han Na, and Hye Seung Jung. "Response: Favorable Glycemic Control With Once-Daily Insulin Degludec/Insulin Aspart After Changing From Basal Insulin in Adults With Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang Et Al.)." Endocrinol Metab (Seoul) 2020.